JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for PHYSIO Archives


PHYSIO Archives

PHYSIO Archives


PHYSIO@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

PHYSIO Home

PHYSIO Home

PHYSIO  June 2001

PHYSIO June 2001

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Murder and Medication?

From:

[log in to unmask]

Reply-To:

- for physiotherapists in education and practice <[log in to unmask]>

Date:

Sun, 10 Jun 2001 18:42:11 EDT

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (212 lines)

[log in to unmask] writes:

< But to be serious: something doesn't add up here. Prozac was welcomed by
the  XTC-using community as a legitimate drug that would have a major "up"
effect. Until they found out that one has to be on the drug for several days
and sometimes even weeks before it takes effect. And those guys here
inAmsterdam will rigorously try any legal pill. >

***  Not only have I witnessed violent episodes occur within the first two
days of acute Prozac usage among several very mild-mannered people, that
possibility has been mentioned clinically.  Unfortunately, there is no way of
predicting which percentage of people may experience those types of
side-effect.  The court transcript did not appear in the news report, but you
could contact the courts concerned to confirm that the defense team took
great pains to hunt of that sort of information.  Anyway, the court decision
is being appealed and no doubt even more of that information will emerge.

By the way, the manufacturers of Prozac even ADMIT in their new patent that
their drug can cause violence.   In a front page article on June 11, 2000 by
Mitchell Zuckoff entitled "Prozac new directions: Science, money drive a
makeover," the Globe followed-up on its original May 7, 2000 article (see
below) revealing that the patent for the new Prozac acknowledges that the
current version of the drug can cause suicidality and violence.

Dr. Glenmullen who has written a new book on this subject (see the review
below) is quoted by the Globe as saying: "Lilly's (the manufacturers of
fluoxetine) efforts to discredit clinicians, scientists, and journalists
trying to foster greater discussion, research, and awareness of this side
effect is one of the most disgraceful chapters in American corporate history."

Here is some further information on fluoxetine (Prozac/Paxil):

--------------------------------------------------------------------------

LANCET ARTICLE

The article, "Dangers of fluoxetine" which appeared in the January 18, 1997
issue of Lancet is a letter written by Dr. Robert Bourguignon, of Belgium,
offers more information on this issue. He reports in his letter that he and a
colleague sent questionnaires to 500 Belgium physicians asking for reports of
serious side effects from Prozac.

Dr Bourguignon said in his letter that eleven doctors reported what he
classified as serious events. These side effects which were reported included
"a feeling of going to die" and panic attacks; "great nervousness" during
first 2 weeks of treatment; aggressive behavior coupled with alcohol abuse in
one patient; suicidal ideas leading to "paranoid psychosis;" and in two
patients nervous breakdowns leading to "barely controllable suicide
attempts." The doctor also reported convulsions in two cases.

Dr Bourguignon's letter gives further information about how the questionnaire
was done, as well as describing Eli Lilly's opposition to the questionnaire.
He concludes that "The company's reassurance about Prozac's safety of use and
efficiency causes some practitioners not to monitor their depressive patients
closely enough. Eli Lilly's denial of the existence of these side-effects and
refusal to discuss them gives cause for concern. "

--------------------------------------------

BOOK ON PROZAC

Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other
Antidepressants
with Safe, Effective Alternatives

Roughly 28 million Americans -- one in every ten -- have taken Prozac,
Zoloft, or Paxil or a similar antidepressant, yet very few patients are aware
of the dangers of these drugs, nor are they aware that better, safer
alternatives exist.

by Joseph Glenmullen, M.D.

ISBN:  0684860015

Now Harvard Medical School's Dr. Joseph Glenmullen documents the ominous
long-term side effects associated with these and other serotonin-boosting
medications.

These side effects include neurological disorders, such as disfiguring facial
and whole-body tics that can indicate brain damage; sexual dysfunction in up
to 60 percent of users; debilitating withdrawal symptoms, including visual
hallucinations, electric shock-like sensations in the brain, dizziness,
nausea, and anxiety; and a decrease of antidepressant effectiveness in about
35 percent of long-term users.

In addition, Dr. Glenmullen's research and riveting case studies shed
shocking new light on the direct link between these drugs and suicide and
violence.......

Dr. Glenmullen argues that antidepressant drug therapy is justified only in
moderate to severe cases -- no more than 25 percent of patients currently
taking these drugs -- and that we should avoid patients' exposure to these
drugs whenever possible. The dangerous side effects, he points out, are
caused by Prozac backlash, which is the brain's reaction to artificially
elevated levels of serotonin.

Using vivid real-life stories from his work at Harvard, his private practice,
and the latest medical research, Dr. Glenmullen explains the real role of
serotonin in depression and challenges the popular, hypothetical notion of a
"serotonin deficiency" allegedly corrected by the drugs. He relates the
research history of Prozac and similar drugs, and includes disturbing facts
about the influence of drug companies and HMOs on media representation of
that research.

For dozens of very informative reviews of this revealing book:

<http://www.glenmullen.com/reviews.html#newYorker>

---------------------------------------------------------------------

MORE INFORMATION FROM DR BOURGUIGNON

Here are extracts from another article by Dr Bourguignon on the side-effects
of Prozac:

<http://www.camtech.net.au/malam/reports/prozac.htm>

Robert Bourguignon MD

But is Prozac as safe as its manufacturer says? Or is there a hidden face to
this success? It would seem so. By 1996, the American FDA had received some
40,000 reports of Prozac-associated adverse reactions, many of them quite
serious. As early as the eighties, reports warned of Prozac's potential
dangers. In 1990, Martin Teicher et al, of Harvard Medical School, reported
six cases of "intense suicidal preoccupation" in patients who had been
prescribed the drug (American Journal of Psychiatry, February 1990).
According to the authors, "none of these patients had ever experienced a
similar state during treatment with any other psychotropic drug". This
inspired a wave of further reports and controversy in the medical literature.

In September 1991, in spite of many harrowing accounts from "Prozac
survivors", an advisory committee of the FDA cleared Prozac. Yet "suicidal
ideation" and "violent behaviours" were added to the label as "reported, but
not proven".

In 1994, David Healy (then consultant to Eli Lilly) published an article
entitled "The Fluoxetine and Suicide Controversy, a Review of the Evidence"
(CNS Drugs, March 1994) (1) in which he opines that antidepressants, Prozac
included, can indeed induce suicidal behaviour in a minority of patients.

Since 1990, an organisation set up by former Prozac users who have suffered
adverse events and their relatives, the so-called "Prozac Survivors Support
Group (PSSG), has been active to warn patients against the possible
side-effects of Prozac.

1994 saw a major milestone in Prozac's legal history. As the first of some
160 cases filed, The Fentress Case (popularly known as The Wesbecker Case)
was tried at Louisville, Kentucky (2). Back in 1989, Jo Wesbecker had killed
and wounded several of his coworkers, and thereafter committed suicide, a few
weeks after starting a Prozac treatment. By a divided 9 to 3 vote (the
smallest possible margin), the jury denied the plaintiffs' claim against
Lilly, but Judge John Potter's doubts about the proceedings led him to seek
to be authorised to carry out further hearings.

Ultimately, the Kentucky Supreme Court granted him the right to do so in
early 1997.  Thus it came to light that the plaintiffs had reached a secret
deal with Lilly. In spite of their original denials, both parties have now
admitted the deal, but they are still refusing to divulge the details. An
attorney in the know has described the amount involved as one "that boggles
the mind" (see for instance John Cornwell, "The Power to Harm", Viking, 1996)
 .........

In March 1998, I testified in a murder case at an Assizes trial in Belgium. A
man who had shot his partner in 1995 claimed he had done so because of
Prozac. This trial became a national event.  Several people testified to
their bad experiences with Prozac in the media.

It is quite remarkable that Lilly did not use any scientific arguments to
deflect criticism: no new survey was published, although that would have been
the best response to public questioning about the safety of the drug.

In 1993, William Forsyth, a retired businessman residing in Maui, Hawaii,
stabbed his wife to death, then committed suicide ten days after starting
Prozac.  His children are suing Lilly, claiming Prozac is to blame for their
father's acts.  Eli Lilly sought "summary judgement", but on January 5, 1998,
Judge Alan Kay decided there were sufficient grounds for the case to be tried
before a federal jury in Honolulu.  Having been postponed
several times, this trial is now scheduled to take place in March 1999.

In July 1997, I was asked to testify at the Forsyth trial. Besides some other
practitioners, also David Healy will act as an expert witness for the
plaintiffs.

It is my opinion that Prozac can induce psychotic episodes in a small
percentage of patients (5-7%), especially those with borderline or manic
personalities. In a small minority of these people, psychosis manifests
itself by
dangerous behaviours such as self-mutilation and suicidal/homicidal ideation
and acts. So far, Lilly has refused to conduct (or publish the results of)
double-blind studies specifically developed to find out more about these
possible side-effects. In my opinion, by refusing to do so, Lilly fails to
meet normal standards in health care.

In my opinion Lilly unduly reassures doctors and patients, while neglecting
doctors' and patients' reports by calling them "anecdotal". It would appear
that Lilly is prepared to go to great lengths to protect Prozac sales.

---------------------------------------------------------

FURTHER WEB RESOURCES ON PROZAC

<http://www.breggin.com/prozac.html>
<http://www.garynull.com/Documents/prozac1.htm>
<http://www.garynull.com/Documents/prozac2.htm>
<http://www.breggin.com/bulletinprozac5.html>

------------------------------------------------------------

Dr Mel C Siff
Denver, USA
http://groups.yahoo.com/group/Supertraining/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

March 2024
February 2024
December 2023
October 2023
August 2023
July 2023
June 2023
May 2023
April 2023
December 2022
October 2022
September 2022
May 2022
December 2021
November 2021
August 2021
June 2021
May 2021
April 2021
March 2021
February 2021
September 2020
July 2020
April 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
October 2010
September 2010
August 2010
July 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998
August 1998
July 1998
June 1998
May 1998
April 1998
March 1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager